OSE Immunotherapeutics SA

EPA:OSE.PA

6.05 (EUR) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 16.74518.67225.6233.57929.36825.8429.5739.64614.8859.3321.1110.280.185
Short Term Investments 0000002.8612.8822.8815.801000
Cash and Short Term Investments 16.74518.67225.6233.57929.36825.84212.43412.52817.76615.1331.1110.280.185
Net Receivables 4.1381.80500.7721.0740.7472.253012.3230000
Inventory 0000000000.435000
Other Current Assets 49.04910.0013.4522.9642.4967.221.472.9030.5190.0910.8160.0280.004
Total Current Assets 69.93230.47837.244.20639.83233.06223.02423.98636.53816.8761.9270.3080.254
Non-Current Assets:
Property, Plant & Equipment, Net 3.4254.074.9795.4393.7952.7010.9040.4290.110.0650.02500
Goodwill 0000000000000
Intangible Assets 046.40148.78451.12252.652.652.652.652.60000
Goodwill and Intangible Assets 44.0146.40148.78451.12252.652.652.652.652.60000
Long Term Investments 6.400.5240.5810.4550.2440.077-52.4320.099000.0280
Tax Assets 0.1910.1950.1830.1730.1650.2830.2720.2610.1570000
Other Non-Current Assets 0.0010.910000-52.949-0.429-52.856-0.065-0.025-0.0280
Total Non-Current Assets 54.02751.57654.4757.31557.01555.8280.9040.4290.110.0650.0250.0280.028
Total Assets 123.95982.05491.67101.52196.84788.8976.90377.35389.54716.9951.980.3360.282
Liabilities & Equity:
Current Liabilities:
Account Payables 7.7246.364.5632.9557.3894.2844.8266.1962.521.0121.3060.0260.006
Short Term Debt 7.7947.2613.9762.3670.6440.8610.6280.5890.5870.7760.28400
Tax Payables 00.020.0210.0140.0020.020.0860.0010.0080.0050.0020.0030.008
Deferred Revenue 00.3470.8121.0461.0874.8110.5744.0710.6640.098-0.28400
Other Current Liabilities 4.7034.8116.89610.385.0064.3542.9613.6414.8840.4140.2970.0240.07
Total Current Liabilities 20.22118.79916.26816.76214.12814.339.07514.49718.6632.3051.8890.0530.084
Non-Current Liabilities:
Long Term Debt 38.33838.5440.81734.76718.8710.6243.8324.2961.1970.2040.8941.1470.831
Deferred Revenue Non-Current 0.10.0013.5863.9652.3181.4131.8221.43-3.8060000
Deferred Tax Liabilities Non-Current 1.0741.3111.5141.7482.085.0662.012.8665.0030000
Other Non-Current Liabilities 0.4150.4290.5240.7090.5310.3772.2420.2480.1590.01000
Total Non-Current Liabilities 39.92740.2842.85537.22421.48116.0673.8324.2961.1970.2040.8941.1470.831
Total Liabilities 60.14859.07959.12353.98635.60930.39715.14921.90725.0222.5192.7831.20.915
Equity:
Preferred Stock 00.15500000.0570.01602.641.2730.2780
Common Stock 4.3884.333.7053.7053.5973.0012.9632.8982.8582.011.6050.5270.527
Retained Earnings -17.871-23.003-35.889-21.11-7.48534.1135.49-10.50320.666-5.584-2.835-0.25-1.436
Accumulated Other Comprehensive Income/Loss 0-0.309-0.22-0.15-0.104-0.1-0.057-0.01626.746-2.64-1.273-1.1420
Other Total Stockholders Equity 77.29441.64846.93360.8365.239.54153.30163.05121.5820.691.70.0010.276
Total Shareholders Equity 63.81122.82132.54747.53561.23858.49361.75455.44664.52514.476-0.803-0.864-0.633
Total Equity 63.81122.82132.54747.53561.23858.49361.75455.44664.52514.476-0.803-0.864-0.633
Total Liabilities & Shareholders Equity 123.95982.05491.67101.52196.84788.8976.87777.31889.54716.9951.980.3360.282